Enveric Biosciences (ENVB) Share-based Compensation (QoQ) (2021 - 2026)
Enveric Biosciences (ENVB) Share-based Compensation (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Enveric Biosciences | 5.58 Mn | -2.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 257.65% |
| Dec 31, 2025 | -196.91% |
| Sep 30, 2025 | 193.86% |
| Jun 30, 2025 | 23,452.17% |
| Mar 31, 2025 | -99.77% |
| Dec 31, 2024 | 2.76% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 5.04% |
| Mar 31, 2024 | -3.63% |
| Dec 31, 2023 | 11.11% |
| Sep 30, 2023 | -60.23% |
| Jun 30, 2023 | 70.27% |
| Mar 31, 2023 | -8.43% |
| Dec 31, 2022 | -10.30% |
| Sep 30, 2022 | -5.20% |
| Jun 30, 2022 | -13.50% |
| Mar 31, 2022 | -97.90% |
| Dec 31, 2021 | 7,803.04% |
| Sep 30, 2021 | -44.52% |
| Jun 30, 2021 | -78.00% |